Joel Greenblatt acquired 4.91 Thousand Haemonetics shares worth $334 Thousand. That's 0.00% of their equity portfolio (1145th largest holding). The first Haemonetics trade was made in Q1 2011. Since then Joel Greenblatt bought shares seventeen more times and sold shares on 23 occasions. The investor's estimated purchase price is $394 Thousand, resulting in a loss of 15%.